SCHEMBL20525822

SCHEMBL20525822

COc1c(OCC2CCNCC2)ccc2c(Oc3ccc(NC(=O)C(=O)NCc4ccc(Cl)cc4)cc3F)ccnc12

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.47
FLT3 P36888 2/20 0.41
KDR P35968 2/20 0.38
AXL P30530 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525722 0.95 MET (0.46) METFLT3KDRAXL
SCHEMBL20525565 0.94 MET (0.47) METFLT3KDRAXL
SCHEMBL20525653 0.94 MET (0.48) METFLT3KDRAXL
SCHEMBL20525829 0.94 MET (0.47) METFLT3KDRAXL
SCHEMBL20525650 0.94 MET (0.49) METFLT3KDRAXL
SCHEMBL20525751 0.94 MET (0.47) METFLT3KDRAXL
SCHEMBL20525667 0.93 MET (0.53) METFLT3KDRAXL
SCHEMBL20525691 0.93 MET (0.47) METFLT3KDR
SCHEMBL20525659 0.92 MET (0.46) METFLT3KDRAXL
SCHEMBL20525693 0.92 MET (0.48) METFLT3KDRAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed